BA
FLGT icon

BlackRock Advisors’s Fulgent Genetics FLGT Stock Holding History

BlackRock Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$23K Buy
+2,014
New +$19K ﹤0.01% 3426

Other funds holding FLGT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Scholtz & Company Stamford, Connecticut $200M AUM 12.67% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
NFA
Nationwide Fund Advisors Columbus, Ohio $2.42B AUM 17.68% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

BlackRock Advisors's FLGT Position: Q4 2016 in Review

BlackRock Advisors opened a new position in Fulgent Genetics (FLGT) in Q4 2016: 2,014 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #3426 among its holdings.

37 funds tracked by Wall St. Rank hold FLGT as of Q4 2016.

  • BlackRock Advisors held 2,014 shares of Fulgent Genetics worth $23K as of Q4 2016.
  • Fulgent Genetics was a new BlackRock Advisors position in Q4 2016.
  • Fulgent Genetics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3426 holding.
  • 37 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.